[Diagnosis, treatment and follow up of prostata cancer]

Birkhäuser, Frédéric D; Thalmann, George N (2008). [Diagnosis, treatment and follow up of prostata cancer]. Therapeutische Umschau, 65(6), pp. 323-8. Bern: Huber

Full text not available from this repository. (Request a copy)

Prostate cancer is the most frequent diagnosed malignancy in men with an increasing incidence. In well informed men between the age of 50 and 70 years screening should be offered when requested. Not every newly diagnosed prostate cancer requires immediate treatment. Curative treatment should be offered to men with a minimal life expectancy of 10 years. In men older than 50-75 years, therefore further screening is not necessary due to a lack of a therapeutic consequence. Curative treatment options enclose as the gold standard surgical removal, i.e. open radical prostatectomy with pelvic lymph node dissection, and radio-oncologic treatments, be it percutaneous radiation therapy, brachytherapies or a combination thereof. Palliative treatment options are mainly hormonal treatment (medical or surgical androgen deprivation), local radiation, treatment with bisphosphonates, chemotherapy and surgical desobstruction of the prostate. Regular follow up allows for early detection of recurrences and an active treatment concept.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology
UniBE Contributor:	Thalmann, George
ISSN:	0040-5930
ISBN:	18622955
Publisher:	Huber
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 15:04
Last Modified:	05 Dec 2022 14:19
PubMed ID:	18622955
Web of Science ID:	A1985ATN3700008
URI:	https://boris.unibe.ch/id/eprint/28003 (FactScience: 115439)